Morning Briefing
Summaries of health policy coverage from major news organizations
High Court's Medical Malpractice Case Pits State Laws Against Federal Laws
Should federal courts be required to abide by state laws when they consider interstate malpractice cases? The Supreme Court mulled that exact issue in a case it heard earlier this week. The case, known as Berk v. Choy, involves a Florida man, Harold Berk, who injured his foot and ankle while in Delaware. He then sued the physician who treated him in Delaware state court, arguing that the treatment made his condition worse. (Frieden, 10/9)
More health industry developments 鈥
Blue Cross Blue Shield of Massachusetts is offering voluntary separation packages to roughly 18% of its workforce due to ongoing financial challenges. The buyout is available to members of its staff who are 55 years or older with at least a decade of service, a spokesperson for the insurance company said Thursday. BCBSMA employs about 4,200 people. (DeSilva, 10/9)
Medicare Advantage insurers suffered another disappointing year under the Star Ratings quality measurement program. The average Medicare Advantage star rating for 2026 is essentially flat at 3.66, compared with 3.65 for 2025, according to data the Centers for Medicare and Medicaid Services released Thursday. (Tepper and Broderick, 10/9)
Two-thirds of Americans, including more than 7 in 10 women, are worried about their ability to pay medical bills, according to polling from The 19th and SurveyMonkey.聽It鈥檚 not just medical bills: Women are also more worried than men about paying for groceries, child care, housing and retirement, the polling finds. But the stress that medical bills place on Americans is particularly relevant as the fight over health care costs keeps the government shuttered.聽(Rupar, 10/9)
In the early 1980s, Thomas Brown was working as a psychologist in Hamden, Conn., when he was asked if he would consider working with students at a tony preparatory school called Hamden Hall Country Day School. Each student was assigned an adviser, but there were a few who needed extra support. There was no money in the part-time job, but in exchange, Brown could send his two children to the school free. As he settled into the position, Brown began to notice a pattern among some of the students sent his way. Particularly the boys. There was a cohort who had a hard time sitting still at their desks. If they were passionate about a topic, they could focus on it intensely. If they weren鈥檛, their minds drifted. They forgot to do assignments and fell behind in class, even though many of them were bright. (Kornelis, 10/9)
In pharma and tech updates 鈥
In December 2009, Bradley Burnam woke up to see a horrifying sight in the mirror. 鈥淭his whole side of my head was black, and my ear was like twice its normal size and hot because it was infected,鈥 he said. 鈥淥bviously terrifying.鈥 Burnam had picked up a deadly superbug, Carbapenem-resistant Enterobacteriaceae, or CRE for short. It鈥檚 70% fatal once it enters the bloodstream. (Attkisson, 10/9)
With a flurry of startup activity, tech to monitor the symptoms of Parkinson鈥檚 disease is gaining traction in care. On Thursday, Kneu Health, a startup spun out of Oxford University research labs, announced $5.6 million in funding for its smartphone app-based platform that measures movement, speech, and cognitive changes in people with Parkinson鈥檚 over time. (Aguilar, 10/9)
The Food and Drug Administration has begun issuing early alerts for all medical devices, following a pilot program that covered just five device types. The recently announced move is part of the agency鈥檚 effort to reduce the time between when it spots a high-risk device issue and warns the public. The communications process used to take months. (Dubinsky, 10/9)
The Food and Drug Administration has cleared a range of medical devices for clinical use, granted De Novo classification for a cryoablation system and awarded Breakthrough Device designation for a neurodegeneration test. Most of the devices received 510(k) clearance, meaning they are similar to other devices on the market and considered safe to use. (Dubinsky, 10/9)